- ICH GCP
- Реестр клинических исследований США
- Клиническое испытание NCT02055508
POSITIVE - Study (Part III) Heidelberg (POSITIVE)
Physical Exercise Program in Lung Cancer Patients With Non-operable Disease Undergoing Palliative Treatment
The investigators plan to evaluate, in a randomized, controlled phase III trial in patients with advanced non-small cell lung cancer (NSCLC), the effects of a 24-week exercise intervention program (EIP) on quality of life, physical functioning and immune function parameters. Eligible patients (n=250) will be enrolled in the Clinic for Thoracic Diseases, Heidelberg, over a time period of two years and followed up for a total of 12 months.
Patients will be randomized either to EIP plus Care Management Phone Calls (CMPC) versus CMPC alone (besides a proper symptom and side effect management CMPC ensures the potential influence of social contacts that can be anticipated for the patients in the intervention group).
Our primary aims are to investigate whether a combination of a partly supervised (in- and outpatient) and partly home-based endurance and resistance training improves quality of life (QoL) and lowers levels of fatigue (evaluation via the standardized and validated questionnaires FACT-L and MFI). In addition we propose to evaluate the effects of EIP on tumor specific immune responses. Biomarkers of immune function will be measured by cellular immunity and cytokine and chemokine panels.
Further secondary outcomes include measurement of anxiety, depression and demoralization, physical performance parameters (e.g. improvement in walk distance, muscle strength), as well as overall and progression free survival analyses.
The study builds on a previous feasibility study of a 8 weeks exercise intervention trial in patients with advanced NSCLC with the results being utilized in the design of the here proposed trial.
The investigators hypothesize that patients randomized in the exercise intervention group will show improved QoL and reduced fatigue, as well as improved physical functioning and increased tumor specific immune responses.
Обзор исследования
Статус
Условия
Вмешательство/лечение
Тип исследования
Регистрация (Действительный)
Фаза
- Непригодный
Контакты и местонахождение
Места учебы
-
-
Baden-Württemberg
-
Heidelberg, Baden-Württemberg, Германия, 69126
- Thoracic Oncology Clinic for Thoracic Diseases
-
-
Критерии участия
Критерии приемлемости
Возраст, подходящий для обучения
Принимает здоровых добровольцев
Полы, имеющие право на обучение
Описание
Inclusion Criteria:
- NSCLC stage IIIB/IV
- receiving systemic treatment (palliative radiotherapy accepted)
- BMI > 18
- ECOG (Eastern Cooperative Oncology Group) performance status ≤ 2
- signed informed consent
Exclusion Criteria:
- serious active infection (i.e. requiring an iv antibiotic, antifungal or antiviral agent)
- inability to walk
- immobility (more than two days)
- previously untreated (non-irradiated or non-resected) symptomatic brain metastases;permitted are: (1) previously treated brain metastases [radiotherapy, surgery, dexamethasone dosage 8 mg per day, anti-epileptic therapy]; (2) asymptomatic brain metastases without additional therapy requirement
- severe neurologic impairment (e.g. apoplectic insult, Morbus Parkinson, pareses of extremities)
- severe cardiac impairment (e.g. cardiac insufficiency NYHA (New York Heart Association) > III, myocardial infarction within the last three months, unexplained syncopal events, severe cardiac arrhythmias, high grade aortic stenosis)
- severe respiratory insufficiency
- uncontrolled pain
- abuse of alcohol or drugs reducing compliance to the study
- bone metastasis inducing skeletal fragility
- any circumstance that would impede ability to give informed consent or adherence to study requirements.
Учебный план
Как устроено исследование?
Детали дизайна
- Основная цель: Поддерживающая терапия
- Распределение: Рандомизированный
- Интервенционная модель: Параллельное назначение
- Маскировка: Нет (открытая этикетка)
Оружие и интервенции
Группа участников / Армия |
Вмешательство/лечение |
---|---|
Экспериментальный: Exercise Intervention Program (EIP)
Inpatient periods: The combined resistance and endurance program consist of free weight and rubber band training for major upper and lower body muscle groups respectively of cycling/walking on an ergometer/treadmill 3x/week. Outpatient periods (3x/week at least two/one supervised training sessions): Supervised training sessions in the local outpatient training center will comprise of resistance exercise on machines and endurance training on an ergometer/treadmill. For non-supervised training session during the outpatient period participants will receive an exercise manual for individualized home-based exercising. In weekly phone calls, the advanced practice nurse will review adherence to the intervention and identify problems. Furthermore, the patients will also be asked the same questions as in the CMPC group. |
|
Активный компаратор: Care-Management-Phone-Calls (CMPC)
Patients in this arm will receive a weekly "care-management-phone-call" (CMPC), performed by an advanced practice nurse (APN).
The CMPCs are based on a structured questionnaire, reflecting pain, shortness of breath, disturbed sleep, exhaustion and distress and potentially treatment related side effects (e.g.
infections, polyneuropathy, etc.).
In case of demanding management of symptoms or complaints (e.g.
uncontrolled pain or breathlessness) the treating physician is contacted by the APN to facilitate improvement.
|
Что измеряет исследование?
Первичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
---|---|---|
QoL: Physical Well-Being (FACT-L)
Временное ограничение: assessed after 12 weeks of enrolement
|
The FACT-L (Functional Assessment of Cancer Therapy-Lung) questionnaire comprises of 36 items and deter-mines the quality of life in patients with lung cancer.
It is separated in the subcategories "physical well-being" (PRIMARY OUTCOME), "emotional well-being", "social well-being", "functional well-being and disease-specific items".
It is widely used in clinical studies and was already applied in exercise intervention studies in lung cancer patients
|
assessed after 12 weeks of enrolement
|
General Fatigue (MFI)
Временное ограничение: assessed after 12 weeks of enrolement
|
The MFI (Multidimensional Fatigue Inventory) questionnaire (20 items) evaluates the extent of chronic fatigue and is divided into the 5 subscales "general fatigue", "physical fatigue", "mental fatigue", "reduced motivation" and "reduced activity".
The MFI questionnaire is widely used in oncological studies and an adequate number of comparative samples exists.
|
assessed after 12 weeks of enrolement
|
Вторичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
---|---|---|
Physical Performance (endurance and strength capacity)
Временное ограничение: assessed every 3 month after enrolement until month 12
|
6-Minute Walk Test (endurance capacity) The 6 minute walk test is feasible and safe to determine patients physical capacity. Patients are instructed to walk in 6 min. as many meters as possible with oxygen saturation and pulse rate being measured concomitantly. Hand-held Dynamometry (isometric strength capacity) The hand-held dynamometry is a standardized instrument to measure muscular strength. In the study 6 major muscle groups of upper and lower extremities will be assessed for their isometric power. |
assessed every 3 month after enrolement until month 12
|
Psychosocial Parameters (e.g. depression, anxiety, demoralization)
Временное ограничение: assessed every 3 month after enrolement until month 12
|
PHQ(Ultra-Brief Patient Health Questionnaire)-4 : The PHQ-4 (Ultra-Brief Patient Health Questionnaire) questionnaire is a short instrument comprising of 4 items to detect the extent of depression and anxiety. It provides sufficient diagnostic accuracy for major depression and can be used as a screening instrument in cancer populations. DS (Demoralization Scale) The demoralization scale (DS) is a relatively new developed questionnaire to detect the extent of existential distress in cancer patients. The German version was validated in 2011 and comprises of 24 questions. The results of the validation showed that the concept of demoralization is a useful instrument to describe the different states of existential distress and the individual incapacity to cope effectively with stressful situations. |
assessed every 3 month after enrolement until month 12
|
Overall survival
Временное ограничение: for the period of 1 year after enrolement
|
for the period of 1 year after enrolement
|
|
progression-free survival
Временное ограничение: for the period of 1 year after enrolement
|
for the period of 1 year after enrolement
|
Другие показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
---|---|---|
Adverse Events
Временное ограничение: baseline until 6 month after enrolement
|
Safety analyses will be based on Adverse Events (AE´s), Severe Adverse Events (SAE´s), and Suspected Unexpected Serious Adverse Reaction (SUSARs) recorded during the study.
Of particular interest are AEs, SAEs and SUSARs deemed to be potentially causally related to the endurance and resistance training.
|
baseline until 6 month after enrolement
|
Translational Program / Immunology
Временное ограничение: baseline, 3 & 6 month after enrolement
|
Quantification (Q) of immune cells: Multicolor flow cytometry from cryopreserved Peripheral Blood Mononuclear Cell (PBMC), CD (cluster of differentiation) 4+ and CD 8+ T cells, effector, naïve and activated T cells, regulatory T cells (Treg) and their functional subsets, natural killer cells, B cells, monocytes and monocyte-derived myeloid suppressor cells will be assessed. Q. of tumor antigen reactive effector/memory T cells: Will be done by interferon gamma Enzyme Linked Immuno Spot Assays from PBMC using a panel of defined tumor antigens presented by generated autologous dendritic cells as antigen presenting cells and purified T cells as responder cells. Detection of tumor reactive Treg: Will be done by established Treg specificity assay based on the increased suppressive activity of specifically activated regulatory T cells. Q. of key immune effector molecules: Will be done for app. 14 different cytokines and chemokines from cryopreserved serum samples. |
baseline, 3 & 6 month after enrolement
|
Соавторы и исследователи
Спонсор
Следователи
- Главный следователь: Michael Thomas, Prof. Dr., Thoracic Oncology Clinic for Thoracic Diseases/University of Heidelberg
- Главный следователь: Joachim Wiskemann, Dr., National Center for Tumor Diseases (NCT)
- Главный следователь: Simone Hummler, Dr., Thoracic Oncology Clinic for Thoracic Diseases/University of Heidelberg
Публикации и полезные ссылки
Общие публикации
- Titz C, Hummler S, Schmidt ME, Thomas M, Steins M, Wiskemann J. Exercise behavior and physical fitness in patients with advanced lung cancer. Support Care Cancer. 2018 Aug;26(8):2725-2736. doi: 10.1007/s00520-018-4105-5. Epub 2018 Feb 26.
- Wiskemann J, Hummler S, Diepold C, Keil M, Abel U, Steindorf K, Beckhove P, Ulrich CM, Steins M, Thomas M. POSITIVE study: physical exercise program in non-operable lung cancer patients undergoing palliative treatment. BMC Cancer. 2016 Jul 19;16:499. doi: 10.1186/s12885-016-2561-1.
Даты записи исследования
Изучение основных дат
Начало исследования (Действительный)
Первичное завершение (Действительный)
Завершение исследования (Действительный)
Даты регистрации исследования
Первый отправленный
Впервые представлено, что соответствует критериям контроля качества
Первый опубликованный (Оценивать)
Обновления учебных записей
Последнее опубликованное обновление (Действительный)
Последнее отправленное обновление, отвечающее критериям контроля качества
Последняя проверка
Дополнительная информация
Термины, связанные с этим исследованием
Ключевые слова
Другие идентификационные номера исследования
- POSITIVE-III-S-326/2013
Эта информация была получена непосредственно с веб-сайта clinicaltrials.gov без каких-либо изменений. Если у вас есть запросы на изменение, удаление или обновление сведений об исследовании, обращайтесь по адресу register@clinicaltrials.gov. Как только изменение будет реализовано на clinicaltrials.gov, оно будет автоматически обновлено и на нашем веб-сайте. .
Клинические исследования Продвинутый НМРЛ
-
Centre Oscar LambretUniversity Hospital, LilleПрекращено
-
University Hospital, MontpellierРекрутинг
-
Intergroupe Francophone de Cancerologie ThoraciqueAmgenАктивный, не рекрутирующийNsclc | КРАС П.Г12СФранция
-
Novartis PharmaceuticalsАктивный, не рекрутирующийПродвинутый мутантный EGFR NonSmallSellLungCancer (NSCLC), KRAS G12-мутантный NSCLC, плоскоклеточный рак пищевода (SCC), плоскоклеточный рак головы/шеи, меланомаТайвань, Соединенные Штаты, Нидерланды, Испания, Корея, Республика, Италия, Япония, Канада, Сингапур
-
Advanced BionicsЗавершенныйТяжелая или глубокая потеря слуха | у взрослых пользователей системы Advanced Bionics HiResolution™ Bionic Ear SystemСоединенные Штаты
-
BeiGeneРекрутингМестно-распространенные или метастатические солидные опухоли для фазы 1, эскалация дозы и фаза 2, вводная по безопасности, участники HNSCC, NSCLC и RCC для фазы 2Австралия, Испания, Франция, Италия, Корея, Республика, Польша
-
Shanghai Kechow Pharma, Inc.Прекращено
-
Qilu Hospital of Shandong UniversityНеизвестныйРасширенный NsclcКитай
-
Instituto Oncológico Dr RosellTurning Point Therapeutics, Inc.Рекрутинг
-
PTS International Inc.Завершенный
Клинические исследования Упражнения вмешательства
-
Brigham and Women's HospitalNational Institute on Aging (NIA)ЗавершенныйРевматические заболевания | Красная волчанка, системная | Приверженность, лекарства | ПодаграСоединенные Штаты
-
Meghan MarsacChildren's Hospital of PhiladelphiaЗавершенный
-
Seton Healthcare FamilyUniversity of Texas at AustinЗавершенныйКачество жизни | Хроническое заболевание | Хроническое заболеваниеСоединенные Штаты
-
University of North Carolina, Chapel HillNational Institute of Allergy and Infectious Diseases (NIAID)РекрутингДоконтактная профилактика ВИЧСоединенные Штаты
-
University Medical Center GroningenGGZ Drenthe Mental Health InstitutionРекрутингСердечно-сосудистый риск | Депрессия, униполярная | Депрессия, биполярное расстройствоНидерланды
-
Hospital Clinic of BarcelonaInstitut d'Investigacions Biomèdiques August Pi i Sunyer; University of BarcelonaЗавершенныйЗаболевания печени | Неалкогольная жировая болезнь печени | Образ жизни, ЗдоровыйИспания
-
Kessler FoundationUniversity of Southern California; VA Office of Research and Development; Kessler Institute... и другие соавторыНеизвестныйТравматическое повреждение мозгаСоединенные Штаты
-
Duke UniversityNational Institutes of Health (NIH)Еще не набираютПродвинутый рак | Рак желудочно-кишечного тракта
-
University of Illinois at ChicagoЗавершенный
-
Munich Municipal HospitalTechnical University of Munich; University of RegensburgНеизвестныйИнфаркт головного мозгаГермания